文献速递乳腺MR

有乳腺癌病史女性的监测性乳腺MRI与晚期第二乳腺癌发生的相关性

Surveillance Breast MRI in Women with a History of Breast Cancer: Association with Occurrence of Advanced Second Breast Cancer.
PubMed 文献 · Radiology · 2025-01-01

该单中心回顾性研究纳入3688例乳腺癌术后女性,2130例接受监测性乳腺MRI、1558例未接受,倾向性评分匹配后各1062对。匹配前后监测MRI均与晚期第二乳腺癌风险降低相关(匹配后OR 0.41,95%CI 0.10-0.99,P=.048),非MRI组症状性第二乳腺癌比例更高。

要点

  • 乳腺癌术后监测性MRI与晚期第二乳腺癌风险降低相关,匹配后OR 0.41(95%CI 0.17-0.99,P=.048)。
  • 非MRI组症状性第二乳腺癌比例高于MRI组:匹配前25% vs 6.4%(P=.01),匹配后21% vs 3.2%(P=.003)。
  • 晚期第二乳腺癌定义为T2及以上或淋巴结阳性,或T1c三阴性/HER2阳性。

核心结论

  • 在有乳腺癌病史的女性中,监测性MRI在倾向性评分匹配前后均与晚期第二乳腺癌风险降低相关。

研究设计与样本

  • 单中心回顾性研究,2009年1月至2014年12月接受乳腺癌手术的女性3688例(平均年龄51.1岁±10.5),2130例接受监测MRI、1558例未接受,按13项临床病理特征行倾向性评分匹配后1062对。

诊断标准与关键数值

  • 第二乳腺癌定义为术后至少1年诊断的同侧或对侧乳腺癌;晚期第二乳腺癌定义为T2及以上或淋巴结阳性,或T1c三阴性/HER2阳性。

临床应用与阅片要点

  • 监测性MRI与晚期第二乳腺癌风险降低相关(匹配后OR 0.41,95%CI 0.17-0.99,P=.048),非MRI组症状性第二乳腺癌比例更高(匹配后21% vs 3.2%,P=.003)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Studies on the association between surveillance breast MRI in women with a personal history of breast cancer (PHBC) and advanced second breast cancer are lacking. Purpose To investigate the association between postoperative surveillance breast MRI and advanced second breast cancer in women with a PHBC by using propensity score matching (PSM). Materials and Methods Women who underwent breast cancer surgery between January 2009 and December 2014 were retrospectively identified at a single tertiary center. Second breast cancer was defined as ipsilateral or contralateral breast cancer diagnosed at least 1 year after surgery, and advanced second breast cancer was defined as second breast cancer (a) grade T2 or higher or lymph node-positive or (b) T1c triple-negative or human epidermal growth factor receptor 2-positive. Women who underwent surveillance MRI and those who did not were matched using propensity scores according to 13 clinical-pathologic characteristics. Outcomes were compared using logistic regression analysis. Results Among the 3688 women (mean age, 51.1 years ± 10.5 [SD]), 2130 underwent surveillance MRI (MRI group) and 1558 did not (non-MRI group); 1062 patient pairs were matched. Advanced second breast cancer proportions for non-MRI and MRI groups were 1.7% (27 of 1558 participants) and 0.4% (eight of 2130 participants) before PSM and 1.6% (17 of 1062 participants) and 0.7% (seven of 1062) after PSM. Surveillance MRI was associated with lower odds of advanced second breast cancer before PSM (odds ratio [OR], 0.21 [95% CI: 0.10, 0.47]; P < .001) and after PSM (OR, 0.41 [95% CI: 0.17, 0.99]; P = .048). The proportion of symptomatic second breast cancers was higher in the non-MRI group before PSM (25% [16 of 65 second cancers] vs 6.4% [three of 47]; P = .01) and after PSM (21% [10 of 48] vs 3.2% [one of 31]; P = .003). Conclusion In women with a PHBC, MRI surveillance was associated with lower odds of advanced second breast cancer before and after PSM. © RSNA, 2025 Supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Yoon J, Han K, Nahm S, et al. Surveillance Breast MRI in Women with a History of Breast Cancer: Association with Occurrence of Advanced Second Breast Cancer. Radiology. 2025. PMID: 39772799. doi:10.1148/radiol.240119

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。